INNT
TOTAL INVALIDATION PROCESSED BY THE IB
08/22/2022
Back to search
Official data from USPTO
QGEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
08/22/2022
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
02/25/2010
Registration date
02/15/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/27/2021
Last transaction
08/27/2021
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH-1015 Lausanne, CH
Examiner
WILKE, JOHN
Law office
L40
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a double helix design next to and above the word "QGel".
Holders and representatives
Holders
QGel SA
Representatives
Perla M. Kuhn Fox Rothschild LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and sciencechemicalbiochemical and biotechnological preparations for industrial and scientific purposes; diagnostic preparations excluding those for medical and veterinary purposes; chemical reagents and chemical and biochemical solventsexcluding those for medical and veterinary purposesin particular for the preparation of samples as well as for modifyingmanipulatingmarkingseparatingisolatingpurifyingreproducing and/or analysing biopolymersin particular for proteinsnucleic acidsmacromolecules and biologically active substances; kits comprising chemicals for the preparation of samplesas well as for modifyingmanipulatingmarkingseparatingisolatingpurifyingreproducing and/or analysing biopolymersin particular for proteinsnucleic acidsmacromolecules and biologically active substancesespecially proteins from biological and biochemical samples
Class 5
Pharmaceutical preparations for medical and veterinary purposesmedia for bacteriological cell cultures; diagnostic preparations for medical and pharmaceutical purposesin-vitro diagnostics for use in biochemistryhaematologymicrobiologyimmunology and electrophoresis; diagnostic preparations for medical purposespreparations for medical and veterinary purposesin particular diagnostic preparations for the preparation of samples as well as for modifyingmanipulatingmarkingseparatingisolatingpurifyingreproducing and/or analysing biopolymersin particular for proteinsnucleic acidsmacromolecules and biologically active substances; chemicalbiochemical and biotechnological preparations for medical purposereagents and solvents for the preparation of samplesas well as for modifyingmanipulatingmarkingseparatingisolatingpurifyingreproducing and/or analysing biopolymersin particular for proteinsnucleic acidsmacromolecules and biologically active substances for diagnostic purposes; diagnostics kits for medical or veterinary diagnosesconsisting primarily of polymerspeptidespolymer cross-linking agentssynthesized biochemicalsenzymesadhesion ligandsbioactive growth factorsanimal derived componentshuman derived componentscollagencellsreagents media and salts for use in preparing samplesas well as for modifyingmanipulatingmarkingseparatingisolatingpurifyingreproducing and/or analysing biopolymersin particular proteinsnucleic acidsmacromolecules and biologically active substancesespecially proteins from biological and biochemical samples
Class 42
Chemicalmedical and biological researchresearch in the field of cellular and molecular biology
Publications
History of USPTO decisions and trademark events.
37 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/27/2022
INPC
INVALIDATION PROCESSED
07/27/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/21/2022
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
04/27/2022
C71T
CANCELLED SECTION 71
08/27/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/26/2020
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
02/15/2020
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
06/30/2017
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
06/30/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/29/2017
ES75
TEAS SECTION 71 & 15 RECEIVED
05/30/2017
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/15/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/14/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/23/2011
FIMP
FINAL DISPOSITION PROCESSED
06/23/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/15/2011
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/14/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
02/15/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/30/2010
PUBO
PUBLISHED FOR OPPOSITION
11/30/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/25/2010
ALIE
ASSIGNED TO LIE
10/25/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/12/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/05/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2010
RFNT
REFUSAL PROCESSED BY IB
07/02/2010
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/03/2010
RFRR
REFUSAL PROCESSED BY MPU
06/03/2010
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/03/2010
CNRT
NON-FINAL ACTION WRITTEN
06/02/2010
DOCK
ASSIGNED TO EXAMINER
06/01/2010
MAFR
APPLICATION FILING RECEIPT MAILED
05/12/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/08/2010
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
05/07/2010
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/06/2010
Continuous trademark protection
Get notified about every new filing that threatens QGEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.